Mainz Biomed logo

Mainz Biomed

Saving lives through innovative molecular diagnostic solutions.

30 employees · est. 2021 · Mainz, Germany

VS
Remicalm logo

Remicalm

Enhancing early detection and effective treatment of various cancers with innovative medical imaging and diagnostic devices for better outcomes.

1 employees · est. 2006 · Houston, United States

Remicalm is the older company (2021 vs 2006); Mainz Biomed is the larger of the two.

Side-by-Side Comparison

Mainz Biomed Remicalm
Founded
2021 2006 older
Headquarters
Mainz, Germany Houston, United States
Employees
30 larger 1
Industry
Biotechnology, Health Care Health Care, Manufacturing
Funding Stage
Post Ipo Equity Debt Financing
Total Funding
$77.50M $500.00K
Funding Rounds
3 1
Services
Autonomous Drone Platform, Perimeter Defense & Counter-UAS, Autonomous Demining Systems, Quantum Antenna Technology Not tracked yet
Target Customers
Defense Contractors, Military Organizations, Government Defense Departments, Security Agencies Not tracked yet
Taxonomy
Molecular Diagnostics, Genetic Testing, In-vitro Diagnostics, Colorectal Cancer Detection, Pancreatic Cancer Detection, Early Disease Detection, Biomedical Innovation, Diagnostic Solutions, Life-threatening Conditions, Diagnostic Product Development Medical Imaging, Diagnostic Devices, Cancer Detection, Cancer Treatment, Early Detection, Screening Devices, Imaging Devices, Cancer Diagnostic Devices, Oncology, Cancer Monitoring Devices, Biomedical Devices, Cancer Diagnostics, Cancer Screening
Website
mainzbiomed.com remicalm.com
Mainz Biomed logo

About Mainz Biomed

Mainz Biomed, founded in 2021 and headquartered in Germany, is a biotech company focused on revolutionizing health care through its innovative molecular diagnostic solutions. With the slogan "Saving lives through innovative molecular diagnostic solutions," the company is dedicated to developing user...

Remicalm logo

About Remicalm

Remicalm, LLC is a medical diagnostic and imaging device company established in 2006 and headquartered in Houston, Texas. The company focuses on designing, manufacturing, and marketing innovative medical devices for cancer diagnostic, screening, imaging, and monitoring within the United States. Thei...

We will tell you when either one moves

BounceWatch watches Mainz Biomed and Remicalm for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Mainz Biomed and Remicalm — by email.

Frequently Asked Questions

Mainz Biomed — Saving lives through innovative molecular diagnostic solutions.. Remicalm — Enhancing early detection and effective treatment of various cancers with innovative medical imaging and diagnostic devices for better outcomes.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Mainz Biomed has raised $77.50M while Remicalm has raised $500.00K.
Mainz Biomed and Remicalm operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Mainz Biomed with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Mainz Biomed on 14 May 2026, and Remicalm on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy